Skip to content
GLP-1 Scorecard
Menu
Graded #210

Fifty 410

Fifty 410 is a direct-to-consumer weight-loss telehealth service offering personalized compounded semaglutide and tirzepatide prescribed by licensed providers and prepared by FDA-registered 503A and 503B pharmacies.

Visit Fifty 410We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$99/mo (all doses, compounded)
Tirzepatide
$133/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh Fifty 410 against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Fifty 410 dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value86/100
Dose & formulation72/100
Clinical oversight55/100
Labs & monitoring53/100
Fulfillment71/100
Contract terms37/100

Strengths

  • Transparent public pricing from 99 dollars per month for semaglutide
  • No membership or subscription; pay only for what you need
  • Compounded by FDA-registered 503A and 503B pharmacies
  • Fast 24 to 48 hour provider review
  • Free one to two day shipping

Where it loses points

  • Does not bill insurance directly
  • Compounded GLP-1 is not an FDA-approved finished drug
  • Specific clinician credentials are not publicly disclosed
  • Served-states list is not published on the site
  • FDA issued Aspen Aesthetics dba Fifty 410 a warning letter in February 2026; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Shoppers who want budget-focused buyers wanting transparent no-membership compounded GLP-1 pricing.

Ranked #210 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Aspen Aesthetics dba Fifty 410 in February 2026. See the FDA warning-letter database.

Closest here

The rankings grading nearest Fifty 410 — the realistic shortlist.

The 18 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Fifty 410's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Fifty 410's site. Not medical advice; see our disclosure.

← Back to the scorecard